Enterprise Value
1.477B
Cash
178.4M
Avg Qtr Burn
N/A
Short % of Float
22.51%
Insider Ownership
0.94%
Institutional Own.
-
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
XACDURO Details Acinetobacter infection | Approved Quarterly sales | |
Xerava (eravacycline) Details Intra-abdominal infections | Approved Quarterly sales | |
Giapreza (angiotensin II) Details Septic shock | Approved Quarterly sales |